Open Access
Numéro d'article 01007
Nombre de pages 1
Section Conférences
Publié en ligne 9 mars 2020
  1. Biphosphonates in multiple myeloma : an update network meta-analysis (review). Mhaskar R, Kumar A, Miladinovic B, Djulbegovic B [Google Scholar]
  2. Les cancers en France en 2016. INCa [Google Scholar]
  3. Use of nex target cancer therapies in children : effects on dental development and risk of jaw necrosis : a review. Hernandez M, Phulpin B, Mansuy L, Drox D [Google Scholar]
  4. Diagnosis and management of osteonecrosis of the jaw : a systemtic review and international consensus. Khan AA, Morrison A [Google Scholar]
  5. Zoledronate suppressed angiogenesis and osteogenesis by inhibiting osteoclasts foramtion and secretion of PDGF-BB. Gao S, Zheng G, Wang L, Liang Y, Zhang S, Lao X, Li K, Liao G [Google Scholar]
  6. Evaluation of the treatment strategies for medication-related osteonecrosis of the jaws (MRONJ) and factors affecting treatment outcome : a multi- center retrospective study with propensity score matching analysis. Hayashida S, Soutome S, Yanamoto S, Fujita S [Google Scholar]
  7. Biphosphonate guidelines for treatment and prevention of myeloma bone disease. Lee OL, Horvath N, Lee C, Joshua D, Ho J, Szer J [Google Scholar]
  8. Effect of anti-angiogenesis induced by chemotherapeutic monotherapy, chemotheraputic/biphosphonate combination therapy and anti-VEGFA mAb therapy on tooth xtraction socket healing in mice. Akita Y, Kuroshima S, Nakajima K, Hayano H, Kanai R, Sasaki M, Sawase T [Google Scholar]
  9. Antiresorpitve agent-related osteonecrosis of the jaw ; position paper 2017 of the Japanese allied committee on osteonecrosis of the ja. Yoneda T, Hagino H, Sugimoto T, Ohta H, Takahashi S [Google Scholar]
  10. A multicenter retrospective study of the risk factors associated with medication related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ? Hasegawa T, Kawakita A, Ueda N, Funa-hara R [Google Scholar]
  11. Osteonecrosis of the jaw and non-malignant disease: Is there an association with rheumatoid arthritis? Lescaille G., Coudert A.E, Baaroun V., Javelot M-J, Cohen-Solal M, Berdal, A. et al [Google Scholar]
  12. Clinical Study Evaluating the Effect of Bevacizumab on the Severity of Zoledronic Acid-Related Osteonecrosis of the Jaw in Cancer Patients. Lescaille G., Coudert A.E., Baaroun V., Ostertag A., Charpentier E., Javelot Mj, et al. [Google Scholar]